Mental Health
Research Brief
Psilocybin Completes Second Pivotal Phase 3 Trial, Paving Way for FDA Review in Depression
5 sources · 56d ago
Research Brief
Landmark Study: Integrating Suicide Care Into Routine Primary Care Slashes Attempt Rates by 25%
5 sources · 57d ago
Explainer
Landmark Research: Non-Hallucinogenic 'Psychoplastogen' Molecules Retain Therapeutic Effect for Depression and Anxiety
4 sources · 58d ago
More in Mental Health
ExplainerPsychedelic Medicine
The Evidence Pack: Why the FDA Declined MDMA-Assisted Therapy for PTSD
Regulatory & Methodological Skeptics 40%Psychedelic Researchers & Advocates 30%Patient Advocates & Veterans 30%
5 sources · 60d ago
Addiction MedicineEvidence Pack
FDA Fast-Tracks First Ibogaine Derivative Trial for Alcohol Use Disorder
Psychedelic Medicine Advocates 40%Public Health & Policy Officials 35%Clinical Safety Skeptics 25%
3 sources · 60d ago
ExplainerPsychedelic Medicine
Landmark Phase 3 Trial Finds Single-Dose Psilocybin Provides Six-Month Relief for Severe Depression
Clinical Researchers 44%Healthcare Administrators 33%Patient Advocates 22%
6 sources · 60d ago
ExplainerMetabolic Psychiatry
Landmark Research Suggests Mental Illness Starts in Brain Cells, Shifting Focus From Neurotransmitters to Cellular Metabolism
Metabolic Psychiatry Pioneers 45%Traditional Neurobiologists 35%Clinical Innovators 20%
4 sources · 62d ago
ExplainerPsychedelic Therapy
The Evidence Pack: How the White House Mandate is Accelerating Psychedelic Medicine
Clinical Researchers & Drug Sponsors 40%Veteran & Patient Advocates 35%Regulatory Skeptics 25%
6 sources · 62d ago
Research BriefPsychiatric Care
The Evidence Pack: How the WHO's New Initiative Aims to Close the Schizophrenia Mortality Gap
Public Health Officials 40%Psychiatric Clinicians 35%Patient Advocacy Groups 25%
5 sources · 63d ago
ExplainerPsychiatric Care
HHS Launches Landmark Action Plan to Curb Psychiatric Overprescribing and Promote Safe Deprescribing
Public Health Officials 35%Clinical Psychiatrists 35%Patient Advocacy Groups 30%
6 sources · 64d ago
ExplainerAutism Research
Magnetic Brain Stimulation Significantly Improves Communication in Children with Autism in Landmark Trial
Clinical Researchers 40%Neurodiversity Advocates 35%Pediatric Neurologists 25%
4 sources · 64d ago
ExplainerPsychiatric Medicine
FDA Approves Esketamine as First Monotherapy for Treatment-Resistant Depression
Psychiatric Clinicians 40%Regulatory & Scientific Consensus 35%Clinical Analysts 25%
3 sources · 64d ago
ExplainerBrain Stimulation
Landmark Trial: Non-Invasive Focused Ultrasound Modulates Amygdala, Halving Symptoms in Depression and Anxiety
Clinical Researchers 40%Psychiatric Practitioners 35%Patient Advocates 25%
4 sources · 65d ago
ExplainerBrain Stimulation
Landmark Case: Personalized Deep Brain Stimulation Achieves Rapid Symptom Reduction in Severe Treatment-Resistant OCD
Neuromodulation Researchers 40%Clinical Psychiatrists 35%Patient Advocacy Groups 25%
5 sources · 66d ago
ExplainerPsychedelic Medicine
Single-Dose Psilocybin Therapy Achieves Rapid Reduction in Chronic Suicidal Ideation in Landmark Trial
Psychiatric Researchers 40%Clinical Implementers 30%Patient Advocates 30%
4 sources · 66d ago
ExplainerPsychedelic Medicine
The Evidence Pack: How a Single-Dose Lysergide Derivative is Rewriting Depression Treatment
Clinical Researchers 40%Regulatory & Policy Experts 30%Factlen Editorial Synthesis 30%
5 sources · 67d ago